Early Bird Registration Deadline is August 4, 2017.
The Florida Gastroenterologic Society's Annual Meeting is the leading event for GI professionals in the state of Florida. FGS is joined with members of the SGNA to enhance the full spectrum of individuals working in the gastroenterology field. The introduction and advances of innovative diagnostic techniques and novel therapeutics has created an exciting range of approaches to many important areas of GI disease and patient care. This program is designed to address those compelling and controversial areas in the care of patients with gastrointestinal disease. During this course, multiple topics will be covered include: dietary therapy in patients with eosinophilic esophagitis, emerging therapies in fatty liver disease, the future of therapeutic endoscopy, endoscopic resection of defiant/complex colon polyps, new liver transplant allocation system, and much more. The structure of the program includes a mix of didactic presentations delivered by expert faculty, interactive audience discussions as well as significant question and answer opportunities.
The program is designed for gastroenterologists, gastroenterology trainees, primary care physicians, nurses, physician assistants and nurse practitioners interested in the latest information on diagnostic GI and state of the art treatment of these illnesses.
Accreditation / CME / MOC: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and
the Florida Gastroenterologic Society. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.
The Florida Medical Association designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes
participation in the evaluation component enables the participant to earn up to 8.5 MOC points in the American Board of internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC credit.
Upon completion of this course, participants should be able to:
- Recognize eosinophilic esophagitis and understand short-term and long-term therapies.
- Diagnose and distinguish celiac disease from non-celiac gluten sensitivity.
- Understand the newest treatment modalities for inflammatory bowel disease.
- Understand the latest endoscopic and molecular techniques for colorectal cancer screening.
- Understand the newest phases of healthcare legislation, reform, policy, and quality indicators for reimbursement.
- Distinguish pre-malignant from non-malignant pancreatic cysts and guide the approach to these entities.
- Recognize challenges and approaches to patients with chronic abdominal pain with focus on the difficult patient
encounter and physician burnout.
- Provide a comprehensive approach to the management of liver masses.
- Gain knowledge of total pancreatectomy with islet cell autotransplantation for patients with chronic pancreatitis.
- Obtain hands-on experience with the newest endoscopic platforms and tools.
- Recognize the significance of NASH and newest approaches for its treatment.
- Understand the newest treatments for hepatitis C virus.
- Present current evidence on pharmacologic and endoscopic strategies to prevent the most common complication of ERCP – post-ERCP pancreatitis.
- Recognize the importance of quality metrics and methods for improvement of quality metrics in colorectal cancer screening and surveillance.
- Gain the newest insights into evaluation and management of Barrett’s Esophagus.
- Understand the use of therapeutic endoscopic ultrasound in GI practice.
- Understand the newest therapeutic modalities for treatment of gastrointestinal bleeding.